Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Advances in Biological Regulation
|
October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Leukemia
|
February 22, 2019
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
Matilde Y Follo, Andrea Pellagatti, Richard N Armstrong, et al.
British Journal of Haematology
|
March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study
Aleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Haematologica
|
April 24, 2024
Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia
Marta B Fernandes, A Margarida Gomes, Mariana L Oliveira, et al.
Advances in Biological Regulation
|
November 6, 2019
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M Akula, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation
|
May 4, 2019
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
Shaw M Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation
|
March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Current Pharmaceutical Design
|
March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Linda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
The New England Journal of Medicine
|
May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
Yao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Advances in Biological Regulation
|
October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Leukemia
|
February 22, 2019
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
Matilde Y Follo, Andrea Pellagatti, Richard N Armstrong, et al.
British Journal of Haematology
|
March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study
Aleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Haematologica
|
April 24, 2024
Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia
Marta B Fernandes, A Margarida Gomes, Mariana L Oliveira, et al.
Advances in Biological Regulation
|
November 6, 2019
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M Akula, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation
|
May 4, 2019
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
Shaw M Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation
|
March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Current Pharmaceutical Design
|
March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Linda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
The New England Journal of Medicine
|
May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
Yao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Page
of 9